TY  - GEN
AU  - Davies,Angela M
AU  - Ho,Cheryl
AU  - Metzger,Alex S
AU  - Beckett,Laurel A
AU  - Christensen,Scott
AU  - Tanaka,Michael
AU  - Lara,Primo N
AU  - Lau,Derick H
AU  - Gandara,David R
TI  - Phase I study of two different schedules of bortezomib and pemetrexed in advanced solid tumors with emphasis on non-small cell lung cancer
SN  - 1556-1380
PY  - 2008///0123
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Boronic Acids
KW  - Bortezomib
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Glutamates
KW  - Guanine
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Neoplasms
KW  - Pemetrexed
KW  - Pyrazines
KW  - Survival Analysis
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/JTO.0b013e31815ba7d0
ER  -